INVA
Innoviva
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: INVA
- PE Ratio
As of Jun 3, 2026, the Innoviva stock's PE ratio is 3.01. This takes into account the latest EPS of $7.2 and stock price of $21.7. The PE ratio has decreased by 76% from its last 4 quarters average of 12.7.
INVA PE ratio history
The PE ratio of Innoviva has averaged 11.63 over the last ten years. The current price-to-earnings ratio of 3.01 is 74% less than the historical average. Analyzing the last ten years, INVA's PE ratio reached its highest point in the Jun 2016 quarter at 61.94, when the price was $10.53 and the EPS was $0.17. The lowest point was recorded in the Sep 2022 quarter, when it reached 2.68 with a price of $11.61 and an EPS of $4.33.
Innoviva PE ratio by year
Maximum annual increase: 704.29% in 2024
Maximum annual decrease: -89.4% in 2025
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 4.97 | -89.4% | $19.99 | $4.02 |
| 2024 | 46.89 | 704.29% | $17.35 | $0.37 |
| 2023 | 5.83 | 34.95% | $16.04 | $2.75 |
| 2022 | 4.32 | -18.8% | $13.25 | $3.07 |
| 2021 | 5.32 | -5.17% | $17.25 | $3.24 |
| 2020 | 5.61 | -38.62% | $12.39 | $2.21 |
| 2019 | 9.14 | 105.39% | $14.16 | $1.55 |
| 2018 | 4.45 | -60.79% | $17.45 | $3.92 |
| 2017 | 11.35 | -42.71% | $14.19 | $1.25 |
| 2016 | 19.81 | N/A | $10.7 | $0.54 |
| 2015 | N/A | N/A | $10.54 | -$0.16 |
| 2014 | N/A | N/A | $14.15 | -$1.5 |
| 2013 | N/A | N/A | $28.73 | -$1.67 |
| 2012 | N/A | N/A | $17.92 | -$0.2 |
| 2011 | N/A | N/A | $17.81 | -$1.41 |
Innoviva PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 3.24 | -34.81% | $23.3 | $7.2 |
| Dec 2025 | 4.97 | -48.55% | $19.99 | $4.02 |
| Sep 2025 | 9.66 | -70.67% | $18.25 | $1.89 |
| Jun 2025 | 32.93 | N/A | $20.09 | $0.61 |
| Mar 2025 | N/A | N/A | $18.13 | -$0.95 |
| Dec 2024 | 46.89 | 145.24% | $17.35 | $0.37 |
| Sep 2024 | 19.12 | 162.28% | $19.31 | $1.01 |
| Jun 2024 | 7.29 | 35% | $16.4 | $2.25 |
| Mar 2024 | 5.4 | -7.38% | $15.24 | $2.82 |
| Dec 2023 | 5.83 | -63.65% | $16.04 | $2.75 |
| Sep 2023 | 16.04 | 323.22% | $12.99 | $0.81 |
| Jun 2023 | 3.79 | 12.8% | $12.73 | $3.36 |
| Mar 2023 | 3.36 | -22.22% | $11.25 | $3.35 |
| Dec 2022 | 4.32 | 61.19% | $13.25 | $3.07 |
| Sep 2022 | 2.68 | -71.67% | $11.61 | $4.33 |
INVA Price vs fair value
INVA average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
The current PE ratio of INVA is under its 3, 5 and 10-year averages.
PE comparison
Innoviva's price to earnings (P/E) of 3.01 is lower than the Healthcare sector and the industry average. Looking at the Healthcare sector average of 23.02, Innoviva's price to earnings (P/E) is 87% lower.
INVA PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| INVA Innoviva Inc | 3.08 | $1.64B |
| OPK Opko Health Inc | N/A | $1.1B |
| ORGO Organogenesis Holdings Inc | N/A | $319.11M |
Frequently asked questions
What is Innoviva's PE ratio?
As of Jun 3, 2026, INVA stock has a price to earnings ratio of 3.01.
What is the 3-year average PE ratio for Innoviva (INVA)?
The 3-year average PE ratio for INVA stock is 14.11.
What is the 5-year average PE ratio for Innoviva (INVA)?
The 5-year average PE ratio for INVA stock is 10.39.
What is the highest PE ratio for INVA?
Over the last ten years, the quarterly PE ratio reached its highest level at 61.94 in the Jun 2016 quarter.
How does the current PE ratio for INVA compare to its historical average?
INVA's price to earnings ratio is currently 74% below its 10-year historical average.
Why is Innoviva's PE ratio so low?
INVA's PE ratio of 3.01 is considered low because the company's stock price is trading at a lower multiple of earnings.
How is INVA's PE ratio calculated (Innoviva PE ratio formula)?
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Jun 3, 2026), Innoviva's share price is $21.7. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $7.2. Therefore, Innoviva's price to earnings ratio for today is 3.01. PE RATIO(3.01) = STOCK PRICE($21.7) / TTM EPS($7.2)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.